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Introduction
Chronic obstructive pulmonary disease (COPD) is defined 
by the Global Initiative for Chronic Obstructive Lung 
Disease (GOLD) as a common, preventable and treatable 
disease that is characterized by persistent respiratory 
symptoms and airflow limitation that is due to airway and/
or alveolar abnormalities usually caused by significant 
exposure to noxious particles or gases (1). In order to 
define disease severity and to guide management of COPD 
patients’ symptom assessment, lung function test (LFT) and 
frequency of respiratory exacerbations are evaluated. COPD 
patients are defined by the presence of abnormal pulmonary 
function (i.e., largely irreversible airflow obstruction), 
exhibit specific morphologic changes in the central and 
peripheral airways, lung parenchyma, and pulmonary 
vasculature (2,3).
Lung changes are evaluated by radiological imaging 
as computed tomography (CT), lung scintigraphy 
and magnetic resonance imaging (MRI) (4-9). These 
techniques have much improved our understanding of 
the pathophysiology of this disorder, especially magnetic 
resonance (MR) has risen new insides (10).
New demands on imaging rise since the re-introduction 
of lung volume reduction (LVR) surgery in the 90th and the 
innovation in endoscopic lung volume reduction (ELVR) 
like valves, coils and sealants as well as thermic LVR by 
vapor as successful therapies for emphysema (11-16). 
The beneficial effects of LVR by surgical resection of 
emphysematous lung tissue is caused by its negative impact 
to respiratory mechanics (14,17,18). Understanding these 
relations helps in the use of imaging to assess the presence, 
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severity, and extent of anatomic alterations and to select 
appropriate candidates for undergoing LVR (19,20).
Radiographic assessment of patients considering LVR 
or ELVR has three important functions: (I) establishing 
the diagnosis of emphysema; (II) to depict extent and 
distribution of emphysema; (III) to evaluate for other 
conditions that represent a contraindication to the 
procedure. But imaging can even more: it enables 
preoperative planning in terms of quantifying the lung 
regional amount emphysema and perfusion and simulating 
the effect of surgical resection (20,21). These information 
provided by new techniques as for example dual-energy 
CT (DECT) or functional information from MRI are not 
yet part of guidelines for COPD diagnosis, prognosis or 
management, but are discussed for longitudinal studies 
(22-24). Nevertheless, these information are the decisive 
element in determining whether a patient is likely to 
benefit from the LVR procedure. Different studies have 
shown that the quantification of the extent, the regional 
distribution of parenchymal destruction, in correlation with 
perfusion and with functional data are helpful as outcome 
predictors.
This review provides an overview of current imaging 
modalities and their role in the evaluation of patients 
for LVR in terms of diagnostic assessment, preoperative 
planning and monitoring of outcome. Finally, new tools to 
enable outcome prediction are addressed. 
Role of chest X-ray for emphysema and therapy
The main goal of imaging in line with the evaluation for 
LVR procedures is to quantify the extent and distribution of 
emphysema (25).
Findings in chest radiographs that should be evaluated 
in the initial evaluation of an LVR candidate are additional 
interstitial pulmonary disease other than emphysema, 
significant pleural scarring, and pulmonary nodules (Figure 1).
However, the value of posterior anterior (PA) and lateral 
chest radiograph is limitedly in LVR evaluation: chest 
radiography has only a sensitivity of 40% in detecting 
emphysema (26), and low specificity with high interobserver 
disagreement hamper a reliable and repeatable quantification 
of emphysema severity in COPD patients (27). Nevertheless, 
chest radiography as a fast, widely available, and easy to 
perform imaging modality at low cost and low radiation dose 
plays an important role in follow-up of COPD patients. 
Chest radiography is widely used for postoperative evaluation 
after LVR or after placement of endobronchial valve, sealant 
or coil implantation and its early or late complications such 
as pneumothorax or device displacement. Additionally, chest 
radiography is essential for pneumothorax management in 
endobronchial LVR.
For a better depiction of the extent and distribution 
of emphysema, as well as for a reliable identification of 
absolute contraindication for LVR procedures additional 
evaluation with a chest CT should be performed.
Figure 1 Features of emphysema in conventional radiography. (A) Posteroanterior chest X-ray in a 72-year-old male patient with COPD 
GOLD III showing hyper-expanded lungs with upper lobe predominant emphysema; (B) lateral projection flattening of the diaphragmatic 
domes as well as increased anteroposterior diameter and increased retrosternal airspace can be noted. COPD, chronic obstructive pulmonary 
disease; GOLD, Global Initiative for Chronic Obstructive Lung Disease. 
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Role of CT for assessment of emphysema
Overview
Chest CT as a fast imaging modality with high temporal 
resolution and the possibility of 3D reconstruction and 
quantification is the imaging modality of choice in the 
evaluation of COPD. With regard of LVR, CT is used 
to evaluate the presence of emphysema. It enables the 
quantification and characterisation of the emphysematous 
destructed lung (27). These factors are important to give 
evidence about the effect of LVR for the patient.
Published series, including the National Emphysema 
Treatment Trial (NETT) (12), showed that patients with 
upper lobe predominant or heterogeneous emphysema are 
benefitting the most from LVR. CT is the most important 
imaging modality to assess heterogeneity and distribution of 
emphysema in COPD in order to find candidates who will 
benefit most when undergoing LVR.
CT is also used to identify concomitant conditions/
contraindications to perform LVR such as the presence of 
malignancy and involvement of airways (i.e., tracheomalacia, 
mucus plugging, bronchiectasis, lung compression and 
bronchial wall thickening) (27). In case a suspicious 
pulmonary nodule is detected on CT, it can be elegantly 
removed in the setting of LVR. Additionally, expiratory CT 
is used for the visualization of air trapping but also for the 
evaluation for bronchial wall collapse during expiration (26). 
Quantification
Emphysema is a destruction of the lung parenchyma distal 
to the terminal bronchiole, which radiographically are seen 
as destruction and absence of normal lung parenchyma. 
Three types of emphysema can be distinguished: (I) 
panlobular, (II) centrilobular, and (III) septal emphysema 
and can additionally evaluate the severity and distribution 
of lung changes (26) (Figure 2). Quantification can be 
performed by visual scoring, semiquantitative using 
densitometry or by quantification:
Since visual scoring showed to have a high interobserver 
variability and is neither sensitive nor precise nowadays 
mainly semiquantification and quantification is used for the 
quantification of the amount of emphysema in COPD.
The most widely used semiquantitative method is the 
Goddard score, whereby the radiologist evaluates the 
severity of emphysema at three distinct areas in each lung. 
For each of these six areas, a numerical score of 0 to 4 is 
assigned, in which 0 represents no emphysema, and 4 more 
than 76% of emphysema. In this system, the total score 
can range from 0 to 24. The heterogeneity of emphysema 
itself is also assessed at each location. Results from different 
studies showed a high agreement between readers, if the 
assessment is performed by experienced radiologists or 
pulmonologists (28,29).
But other authors report still a high interobserver 
disagreement of this technique: in the NETT, all observers 
had to undergo training on a set of CT. Despite the use of 
experienced and previously trained chest radiologists, there 
was still significant inter- and intra-observer variability in 
emphysema quantification (12). To reduce interobserver 
variability the presentation of the emphysema can be 
enhanced by simple methods without the use of dedicated 
software, as for example with sagittal volume rendering 
based thin slabs, colour coding the severity and distribution 
of emphysema. This so called “CT densitometry” 
(Figure 3) has a higher accuracy compared to multiplanar 
reconstructions (MPRs) (unpublished data).
Nowadays quantitative methods are the standard of 
reference. Various commercially available software tools can 
perform automated emphysema quantification. The goal 
is to identify the lung parenchyma by virtually removing 
other anatomic structures such as the chest wall and the 
mediastinum. While CT scanning allows the quantification 
of tissue density using Hounsfield units (HU), it can be used 
to assess the density of each voxel within the lung fields. 
Based on CT characteristics to anatomic characteristics of 
the lung a threshold is chosen to distinguish normal lung 
tissue from emphysema (27,30). This threshold ranges 
normally from −850 to −950 HU. Gevenois et al. (31,32) 
recommended a cut-off value for emphysematous lung 
parenchyma on CT scans is −950 HU, which nowadays 
represents the standard for all different software.
Using a lower threshold than −950 HU would lead to 
an underestimation of the presence of emphysema, while 
using a higher threshold than −950 HU would lead to 
overestimation of emphysema. Mathematically the amount 
of emphysema is the percentage of lung tissue below 
the chosen threshold. Both methods (i.e., the observer 
and software based approaches) can be used not only the 
emphysema quantification but also for the classification of 
the anatomic distribution of emphysema (25).
As already discussed, it is very important for the LVR 
evaluation to describe the distribution of lung changes as 
for example in an “upper-lobe predominant” distribution 
or another distribution (25). In the automated system, the 
characterization can be done either using a lobe-based 
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quantification or relative by dividing the lung into thirds 
and used for lung scintigraphy and calculating emphysema 
heterogeneity by the upper to lower zone ratio of low 
attenuation areas (LAAs). It has been shown that the 
preoperative objective LAA ratio correlates with surgical 
outcomes, as shown by improvement of lung function and 
maximal exercise (33). Newer techniques allow depicting 
and quantifying clusters of emphysema, providing inside 
into the heterogeneity (34). These tools are helpful in 
characterising the type and distribution of emphysema 
and allow a primary selection of target areas for LVR or 
endoscopic interventions. Nevertheless, the validation of 
the source images remains crucial. 
Besides the amount and distribution of emphysema, the 
integrity of the fissures plays an important role especially 
for endobronchial valve treatment (19). Incomplete fissures 
mostly contribute to collateral ventilation. Fissure integrity 
can be assessed non-invasively with the Chartis Pulmonary 
Assessment System (35) or non-invasively by using CT. 
Schuhmann et al. demonstrated that quantitative CT led 
Figure 2 Different emphysema distributions on non-enhanced chest CT. (A) Axial reconstruction in a 63-year-old male patient shows 
centrilobular emphysema; (B) it shows emphysema in a 58-year-old female patient with panlobular distribution; (C) it shows axial 
reconstruction in a 67-year-old female patient with paraseptal emphysema; (D) it shows coronal reconstruction in an 82-year-old male 
patient with bullous emphysema. CT, computed tomography. 
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to comparable results to Chartis for classifying LVR and 
is a valuable method to effectively select suitable patients 
for valve-based LVR procedures (36). Usually, in cases 
where fissure integrity is below 95% by quantitative CT, 
bronchoscopic measurements using Chartis technology 
is performed. Complete interlobar fissures were observed 
only in one-third of patients of a large European study 
on endobronchial valves (EBV) LVR (13). Although the 
validation of fissures seems very easy on normal chest CT, 
it can be very difficult especially in patients with severe 
emphysema, which is also reflected in a low interobserver 
agreement (37). In that study, radiologists used MPR 
imaging in both sagittal and coronal planes, which appeared 
to be very helpful to assess fissure integrity.
Studies showed that accurate depiction of affected 
lung parenchyma is crucial for a focalized therapy and to 
improve treatment outcome: Sciurba et al. reported that 
patients were HRCT was used to evaluate distribution 
of emphysema and fissure anatomy to find suitable lung 
regions for endobronchial valve placements had a better 
post-interventional outcome that the control-group (15). 
Different studies show that automated emphysema 
Figure 3 Preoperative imaging before LVR. It shows CT densitometry in a 72-year-old male patient with COPD GOLD III in (A) axial, 
(B) coronal, and (C) sagittal reconstruction as well as the (D) 3D dataset. The apical predominant distribution of emphysema is highlighted 
in blue. The higher the score, the higher the presence of emphysema. Lobe area (LAA) and percentage of lobe area to total lung (LAA%). 
LVR, lung volume reduction; CT, computed tomography; LAA, low attenuation area; COPD, chronic obstructive pulmonary disease; 
GOLD, Global Initiative for Chronic Obstructive Lung Disease. 
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quantification is highly reproducible, when using identical 
scan parameters and reconstruction algorithms. However, 
it has not been shown that automated quantification of the 
extent and distribution of emphysema offers significant 
advantage in predicting if a patient has benefit when 
undergoing LVR over the evaluation by an experienced 
radiologist using a semiquantitative scoring approach (12). 
Currently standardized quantitative methods and 
general guidelines for the assessment of quantitative CT 
are not available, although they are routinely used in the 
clinical practice.
New techniques
Novel techniques for the quantification of emphysema 
are based on DECT. This method can assess pulmonary 
perfusion by measuring iodine distribution maps or 
pulmonary ventilation by measuring the distribution of 
inhaled xenon gas (Figures 4,5) (38). The basis of this 
method is the acquisition of images at different X-ray 
Figure 4 Preoperative imaging before LVR. A 64-year-old male patient with COPD GOLD IV: (A) lower tracer uptake in the lateral 
perfusion map of lung scintigraphy is nicely correlating with lower attenuation on (B) DECT and (C) CT densitometry on sagittal 
reconstruction. (D) It shows axial reconstruction of DECT in the same patient and (E) shows the respective axial slice on non-enhanced 
chest CT showing areas of emphysema in the middle lobe a the lingula. LVR, lung volume reduction; CT, computed tomography; COPD, 
chronic obstructive pulmonary disease; GOLD, Global Initiative for Chronic Obstructive Lung Disease; DECT, dual-energy CT. 
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energies and analysis of attenuation differences, allowing 
to create iodine maps of the lung parenchyma reflecting 
the perfusion, which can provide additional physiological 
information in patients with COPD beyond the pure 
morphological assessment with standard CT (39). This 
novel method in the diagnostic accuracy of standard 
CT leads to a one-stop-shop tool while maintaining its 
advantages over scintigraphy, but adding the structural 
information.
Xenon  enhanced  DECT (XE-DECT)  s tud ie s 
demonstrated that lung zones enhanced by xenon strongly 
correlate with obstructive ventilation impairment (40). 
Similarly, ventilation defects seen on XE-DECT correlate 
significantly with airflow obstruction on LFEs (22,41,42) 
and can be used for visualization of the distribution and 
localization of emphysema in COPD. A recent study by Lee 
et al. concluded that the parenchymal attenuation change 
between inspiration/expiration CTs and xenon dynamic 
change correlate significantly, and might be more robust as 
lung function parameters except FEV1 (22). 
Role of scintigraphy
Another technique, which can be employed to evaluate 
patients with severe emphysema who are candidates for 
LVR is scintigraphy (Figure 6). Scintigraphy allows for 
visualizing ventilation and perfusion of the lungs and is 
therefore able to show upper-lobe predominance and 
Figure 5 Pre-operative imaging before LVR. Preoperative evaluation of a 67-year-old male patient with COPD GOLD III: (A) coronal 
reconstruction of non-enhanced chest CT shows upper lobe predominant emphysema, correlating with areas of lower attenuation on (D) 
coronal reconstruction of DECT and (C) 3D reconstruction of the same DECT dataset. (B) It shows preoperative segmentation of the lungs 
in the different lobes. LVR, lung volume reduction; CT, computed tomography; COPD, chronic obstructive pulmonary disease; GOLD, 
Global Initiative for Chronic Obstructive Lung Disease; DECT, dual-energy CT. 
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heterogeneity of emphysema. Lung scintigraphy is helpful 
to identify the most severely affected parts of the lungs 
in heterogeneous emphysema, but struggles in cases of 
homogeneous emphysema (43). Quantification is done by 
dividing the lung in three distinct areas (i.e., upper, middle 
and lower area) and calculating the percentage of uptake 
of tracers divided into ventilation and perfusion for each 
particular zone.
Several authors showed the high accordance between 
lung perfusion assessed by HRCT and on scintigraphy, 
questioning the additional information scintigraphy for 
lung evaluation making the method superfluous in LVR 
evaluation as mentioned above (7,44). 
Role of MRI
MRI of the lung is the latest imaging tool been introduced 
for the assessment of lung changes. Currently MR still 
plays only a minor role in clinical setting. MRI is mainly 
used as an alternative imaging modality in cases where 
radiation exposure plays a relevant role. However, in the 
last years due to new sequences the role of MR is changing 
and the method more and more achieved a central role in 
lung imaging. MRI is more than any other imaging method 
capable to combine morphologic and functional information 
(45,46). Even though CT might be better in visualizing 
subtle changes in lung parenchyma, the strength of MRI is 
functional imaging: MRI is able to visualize ventilation and 
time resolved lung perfusion, it can show breathing dynamic 
and functional imaging of the diaphragm. 
Lung morphology and function can also be evaluated 
using oxygen enhanced MRI or nobel gases: hyperpolarized 
noble gases or molecular oxygen can be used as an inhaled 
MRI contrast agent which is able to show regional 
ventilation and perfusion.
Similarly, with the administration of blood contrast 
media the signal of the lung during dynamic MRI can 
be postprocessed with the use of calculation of inflow 
over time in order to obtain quantitative parameters for 
pulmonary blood flow, blood volume and mean transit time 
(47,48). These quantitative maps of lung perfusion obtained 
on MR are comparable to perfusion scintigraphy (49,50). 
Dynamic contrast-enhanced MRI has also been propounded 
for the evaluation and monitoring of COPD disease 
severity (51). 
Fourier decomposition lung MRI, a recently introduced 
technique for functional lung imaging has the ability to 
examine the patient without the use of contrast agents. 
It allows the simultaneous assessment of regional lung 
perfusion and ventilation-related information (52). 
Although the acquisition last only 30 seconds and the results 
are promising, the method is not very robust, resulting in 
too many artifacts (53).
Furthermore, MRI is a viable method for the assessment 
of lung volumes and respiratory mechanics: beside the 
upper-lobe predominance and heterogeneity, MRI is also 
able to visualize impaired respiratory motion of the chest 
wall and the diaphragm, which are additional factors in 
Figure 6 Example of lung scintigraphy. A 74-year-old male patient with COPD GOLD IV shows perfusion maps in (A) anteroposterior, (B) 
right oblique and (C) left oblique perfusion maps. Areas with reduced or no tracer uptake correspond to emphysematous areas of the lung. 
COPD, chronic obstructive pulmonary disease; GOLD, Global Initiative for Chronic Obstructive Lung Disease. 
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COPD. Preliminary results of Suga et al. (54) showed 
that with dynamic MRI it is possible to non-invasively 
visualize dynamic respiratory motions of the diaphragm 
and chest wall and to quantify post-operative improvement 
or worsening of patients undergoing LVR and is therefore 
potentially useful for monitoring the effects of LVR (55). 
Which patients should be operated?
In a number of large case series, LVR proved to reduce 
dyspnoea and to improve lung function and wellbeing in 
patients with advanced pulmonary emphysema. The NETT 
trial confirmed these findings and demonstrated that selected 
patients live longer after surgery. Since patient selection is 
crucial to the success of the procedure, treatment should be 
performed at a specialised centre with a multidisciplinary 
team approach on emphysema treatment (12).
The goal of LVR is to remove emphysematous and 
hyper-inflated parts of the lung in order to restore 
respiratory mechanics, to lower air trapping and residual 
volume resulting in better ventilation and increased 
patients’ wellbeing. While studies (12) show that patients 
with heterogeneous or upper lobe predominant emphysema 
profit from LVR, other meta-analyses showed that patients 
with homogeneous distribution of emphysema did not show 
benefit from surgery (56,57).
Contraindications for LVR are severe bronchiectasis, 
large bullae, massive destruction of lung parenchyma and 
malignancy.
Therefore, it is important to assess preoperatively 
heterogeneity and distribution of emphysema in COPD 
and to rule out contraindications in order to find suitable 
candidates for LVR. CT is the standard of reference for 
assessment of emphysema distribution and for preoperative 
planning to predict outcome by simulating the resection. 
Quantitative CT may also be used to simulate the resection. 
Nowadays the different segmentation tools allow besides 
automated lung or lob segmentation also the semiautomated 
segmentation of areas. This enables to analyse the influence 
of resection zones by the thoracic surgeon on the changes 
of destructed lung volume.
Combining surgical planning on quantitative CT with 
parameters from lung function, dynamic MRI and perfusion 
from DECT will allow to predict the outcome and 
therewith a better selection of patients, but also allows to 
stretch the boarders may including patients that currently 
would not have been operated. 
Role of imaging for endobronchial LVR (valves, 
coils)
Less invasive techniques than LVR are the endobronchial 
placement of valves and coils. The goal is to block regional 
inflation, while allowing exhalation in order to reduce 
air trapping and improve lung function (15). The CT-
evaluation of possible candidates undergoing endobronchial 
LVR contains (I) the assessment of the severity and 
anatomic distribution of emphysema (II) the identification 
of the target lobe and (III) the assessment of the 
completeness of interlobar fissures. Santos et al. (58) showed 
that emphysema distribution and fissure integrity were next 
to the lung function the most important factors to predict 
treatment success. Fissures anatomy must be addressed 
before performing LVR procedures of COPD as a marker 
for interlobar collateral ventilation as shown above: patients 
with severe emphysema and complete fissures depicted 
on CT had a better response to endobronchial valve 
placement (2,58). Incomplete fissures constitute interlobar 
collaterals and reduce the positive effects of lobar isolation 
by EBV placement (15). These findings support the use of 
quantitative HRCT in choosing patients which will benefit 
the most from EBV therapy (15). Nowadays computerized 
methods to automatically allowing the quantification of 
fissural integrity are already in use (Figure 7) (36).
Endobronchial LVR utilizing one-way endobronchial 
valves is an accepted treatment for patients with in 
both heterogeneous upper and lower lobe predominant 
emphysema and without interlobar collateral ventilation.
Despite its beneficial, physiologic role in preventing 
atelectasis, collateral ventilation is limiting therapeutic 
success in Endobronchial LVR with valves in severe 
emphysema, whereas LVR coils and polymeric LVR are 
considered independent of collateral ventilation.
Therefore, for patients with collateral ventilation, who 
are not considered candidates for valve treatment, and for 
patients with homogeneous emphysema, the introduction 
of LVR coil treatment is a promising solution. The use of 
biochemical sealant is restricted to emphysema of upper-
lobe predominance.
After endobronchial LVR procedure, the indications 
for a chest radiography or chest CT include a check 
for pneumothorax, control of adequate placement 
of implanted devices, detection of device migration, 
evaluation of therapeutic success or any subsequent 
clinical encounters.
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Conclusions
Besides clinical examination and LFT, imaging is one of the 
key factors for the success of surgical or minimal invasive 
therapy of severe lung emphysema. Especially CT with 
its increasing possibilities in assessing lung structure has 
brought additional insides into the pathology and supports 
thoracic surgeons and interventional pneumologists in 
selecting patients and optimising LVR procedures but also 
enables the development of new endovascular therapies. 
Emerging techniques as MR and DECT will further 
improve the individual outcome by supporting the choice of 
optimal therapy.
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